Adding Bevacizumab to Olaparib Boosts Survival Only in BRCA-Mutated Ovarian Cancer
A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...
Tag: Biomarker-driven therapy
Choosing First-Line Therapy for Chronic Lymphocytic Leukemia
In the rapidly evolving landscape of hematologic malignancies, chronic lymphocytic leukemia (CLL) continues to pose intricate challenges regarding the optimal ...
POPULAR NEWS
-
Recessive Ciliopathy Variants Identified in Adult Iraqi Kidney Disease Cohort
-
Review Details Spatial Transcriptomics Applications and Spatial Disease Units in Cardiovascular Medicine
-
Electronic Community Health System Linked to Higher Maternal Care Retention in Ethiopia
-
Brace-Free ACL Rehabilitation Matches Long-Term Outcomes Over Five Years